BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21526180)

  • 1. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.
    Jeong HW; Cui W; Yang Y; Lu J; He J; Li A; Song D; Guo Y; Liu BH; Chai L
    PLoS One; 2011 Apr; 6(4):e18372. PubMed ID: 21526180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype.
    Yang WJ; Song MJ; Park EY; Lee JJ; Park JH; Park K; Park JH; Kim HP
    Mol Cells; 2013 Oct; 36(4):368-75. PubMed ID: 23996530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia.
    Huang FF; Zhang L; Wu DS; Yuan XY; Yu YH; Zhao XL; Chen FP; Zeng H
    PLoS One; 2014; 9(3):e88298. PubMed ID: 24603487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
    Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
    Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
    Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
    Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
    Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
    Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistance.
    Hupfeld T; Chapuy B; Schrader V; Beutler M; Veltkamp C; Koch R; Cameron S; Aung T; Haase D; Larosee P; Truemper L; Wulf GG
    Br J Haematol; 2013 Apr; 161(2):204-13. PubMed ID: 23432194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.
    Dai Y; Liu S; Zhang WQ; Yang YL; Hang P; Wang H; Cheng L; Hsu PC; Wang YC; Xu Z; Jablons DM; You L
    Oncotarget; 2017 Jan; 8(3):4096-4109. PubMed ID: 27911857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.
    Marzac C; Garrido E; Tang R; Fava F; Hirsch P; De Benedictis C; Corre E; Lapusan S; Lallemand JY; Marie JP; Jacquet E; Legrand O
    Haematologica; 2011 Sep; 96(9):1293-301. PubMed ID: 21606172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
    To KK; Polgar O; Huff LM; Morisaki K; Bates SE
    Mol Cancer Res; 2008 Jan; 6(1):151-64. PubMed ID: 18234970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
    Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
    Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells.
    Zhang S; Wang Y; Mao JH; Hsieh D; Kim IJ; Hu LM; Xu Z; Long H; Jablons DM; You L
    PLoS One; 2012; 7(6):e38996. PubMed ID: 22768056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.
    Yang B; Ma YF; Liu Y
    Drug Res (Stuttg); 2015 Oct; 65(10):526-31. PubMed ID: 25368906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
    Bram EE; Stark M; Raz S; Assaraf YG
    Neoplasia; 2009 Dec; 11(12):1359-70. PubMed ID: 20019844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.
    Huang FF; Wu DS; Zhang L; Yu YH; Yuan XY; Li WJ; Chen XP; Zhao XL; Chen FP; Zeng H
    Cancer Lett; 2013 Aug; 336(1):96-105. PubMed ID: 23603434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.
    Natarajan K; Bhullar J; Shukla S; Burcu M; Chen ZS; Ambudkar SV; Baer MR
    Biochem Pharmacol; 2013 Feb; 85(4):514-24. PubMed ID: 23261525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of ABCG2 expression in adult AML blast samples.
    Abbott BL; Colapietro AM; Barnes Y; Marini F; Andreeff M; Sorrentino BP
    Blood; 2002 Dec; 100(13):4594-601. PubMed ID: 12393637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
    Ho MM; Hogge DE; Ling V
    Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.